help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baumann, G.
Right arrow Articles by Schwartz, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baumann, G.
Right arrow Articles by Schwartz, J.

Journal of Clinical Endocrinology & Metabolism, Vol 72, 1346-1349, Copyright © 1991 by Endocrine Society


ARTICLES

Short stature and decreased serum growth hormone-binding protein in the Mountain Ok people of Papua New Guinea

G Baumann, MA Shaw, RC Brumbaugh and J Schwartz
Department of Medicine, Northwestern University Medical School, Chicago, Illinois 60611.

Two circulating GH-binding proteins (GH-BP), one of which is related to the GH receptor, have been described. To assess their possible role in or link with determining statural growth, we measured their activity/level in the serum of 25 adult subjects from a short-statured population from the highlands of Papua New Guinea (Mountain Ok people, similar in stature to African pygmies) and in 25 normal-statured North American control subjects. The Mountain Ok people have normal levels of GH, insulin-like growth factor-I (IGF-I), IGF-II, and serum albumin and prealbumin in association with short stature, making them a unique study population. Levels of the high affinity (GH receptor-related) GH- BP were significantly lower in the Mountain Ok subjects than in the taller controls (5.2 +/- 3.0% vs. 10.6 +/- 3.9% GH bound/160 microL, respectively; mean +/- SD; P less than 0.001). In contrast, the low affinity GH-BP was comparable in Mountain Ok and control subjects. Because of the structural similarity between the GH receptor and GH-BP, these data suggest that a limitation in GH receptor/GH-BP endowment may be associated with short stature despite normal circulating IGF-I levels. Alternatively, it is possible that the GH-BP itself plays an important role in growth promotion. Thus, the GH receptor (and/or GH- BP) complement may be a determinant of the genetically programmed height achieved.


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
S. Jain, D. W. Golde, R. Bailey, and M. E. Geffner
Insulin-Like Growth Factor-I Resistance
Endocr. Rev., October 1, 1998; 19(5): 625 - 646.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1991 by The Endocrine Society